Clinical Trial Update: A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for an adjuvanted protein-based Hepatitis C vaccine candidate; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• HCV Adjuvanted Protein-based Vaccine Candidate

Snippet

Sponsor: University of Alberta | Conditions: Hepatitis C | Phase 1 | Status: NOT_YET_RECRUITING